To The Moon

A strong SGD affects daily life as it helps to reduce importing inflation. A strong currency also allows us to get greater bang for the buck when we travel overseas especially to neighbouring Malaysia for grocery, shopping and food. It also helps us investors when we buy non-SG stocks like the US and HK stocks. I definitely will not put my market in fixed deposit as it cannot even match inflation. Investing through Tiger brokers or using Tiger vault is definitely the wiser option, especially in the longer run. @Universe宇宙 @Wayneqq @HelenJanet @Success88

小虎們，港股最近新股瘋狂飆漲！驚艷各位投資者們！$映恩生物(09606)$今日上市首掛便飆升超130%！ 此外次新股 $赤峯黃金(06693)$ 昨日也大漲超6%，年初至今回報收益率也接近93%！新茶飲美股第一股 $霸王茶姬(CHA)$ 也正式開啟招股，此前破發的港股新股與次新股表現都十分強勁！包括蜜雪冰城，布魯可等累計漲幅都超100%！事實上今年傳聞還有眾多IPO將赴港上市，包括寧德時代，豐巢控股，京東工業，元光科技，香江電器，派格生物，百利天恆，奧克斯電氣，容大合樂，風華秋實，羣核科技，週六福，菜鳥物流等！那麼4月中旬後有哪些港股新股將上市？你認為誰會是下一個映恩呢？映恩生物今日上市首掛飆升132%映恩生物首日狂飆，ADC賽道成焦點今日（2025年4月15日），港股市場迎來一顆重磅新星—— $映恩生物(09606)$ 。這家專注於抗體偶聯藥物（ADC）研發的創新藥企，上市首日開盤即暴漲91.33%，盤中最高漲幅超130%，成為今年港股18A板塊最亮眼的IPO之一。其強勁表現不僅刷新了投資者對生物科技股的預期，更被視為港股18A行業的「分水嶺」——若後續臨牀管線及商業化進展順利，或將重振市場對創新藥企的信心。映恩生物為何能引爆市場？1. 技術壁壘與管線優勢映恩生物擁有12款自主研發的ADC候選藥物，其中6款已進入臨牀階段，核心產品DB-1303（靶向HER2癌症）和DB-13

I opened 1.0 share(s) $Global X Nasdaq 100 Covered Call ETF(QYLD)$ ,🌟🌟🌟QYLD has a laser focus on providing dividend income through a Covered Call Strategy in which it buys stocks in the Nasdaq 100 Index and "writes" or "sells" corresponding call options on the same index. The current dividend yield is 12.94%. The best part is that Dividends are paid every month. QYLD goes ex dividend on April 21. How good is that! 😍😍😍🌈🌈🌈💰💰💰 @TigerClub @CaptainTiger @Tiger_comments @TigerStars &nb

These three REITs have the right attributes to provide income investors with peace of mind.